Comments for CELG - Stockpickr! Your Source for Stock Ideas

Comments for CELG

Added By	Comments	Type	Date Added
bampsbe1	1 of best in health space	Love	October 13, 2009
barrons3	In the latter theory the big durable good numbers and existing-home numbers are "in" the stock market. I say that because some of my hardest-hit names are directly linked to a stronger economy -- 3M (MMM), Caterpillar (CAT), Deere (DE), Fluor (FLR) and General Electric (GE) -- while the recession stocks are rocking: Procter & Gamble (PG), Celgene (CELG), General Mills (GIS), Pepsi (PEP), Coca-Cola (KO) and Abbott Laboratories (ABT). Worse, Dollar Tree (DLTR) and Family Dollar (FDO) are on the move.	Love	August 27, 2009
LBatista	Biotech	Love	August 12, 2009
Stockpickr Staff	Adam Feuerstein: "MYGN has been a highflying growth stock since last year (the chart is a marvel), but as we've seen with other high P/E stocks like Celgene (CELG), the crash comes when the company can't keep up with the ever-increasing demands for growth, growth and more growth." <a href="http://www.thestreet.com/story/10496626/2/top-takes-from-realmoney.html" target="_blank">Read the full article here.</a>	Love	May 05, 2009
Stockpickr Staff	"This is a hated group, but I bought more for my trust when it went down and I'm a bull on Celgene." (<a href="http://www.thestreet.com/story/10491721/1/mad-money-lightning-round-buy-general-dynamics.html" target="_blank">"Mad Money Lightning Round," 4-24-09</a>)	Love	April 27, 2009
bullbat	Undervalued cancer therapeutic	Love	April 27, 2009
h8tow8	Long term growth	Love	April 24, 2009
triboa	early cycle growth	Love	April 19, 2009
Nicson51	A dog in a manager	Hate	April 19, 2009
mario pugliani	cramer	Love	April 16, 2009
ebaycarbuyers	great company with a beat up stock	Love	April 15, 2009
Stockpickr Staff	In the meantime, the rotation into the staples continues. I have said and I reiterate that Pepsi (PEP), Coke (KO), Abbott (ABT), Celgene (CELG) and Gilead (GILD) are buys. (<a href="http://www.thestreet.com/p/_tsc/rmoney/jimcramerblog/10483181.html" target="_blank">"What to Do Now," 4-7-09</a>)	Love	April 08, 2009
Stockpickr Staff	Cramer made is clear that he's not a buyer of stocks at current levels. He told viewers that if they have 40% to 50% gains in their stocks, they need to take profits and not be pigs. However on any weakness, Cramer said he is a buyer, especially names like Celgene (CELG), a stock which he owns for his charitable trust, Action Alerts PLUS, and one that was featured yesterday, which hasn't participated in the rally thus far. (<a href="http://www.thestreet.com/story/10482248/1/cramers-mad-money-recap-a-genuine-rally.html" target="_blank">"Mad Money," 4-3-09</a>)	Love	April 06, 2009
lyndafranzen	biotech play	Love	April 05, 2009
quaillover	cancer	Love	April 03, 2009
barrons3	Look at the money flowing into Celgene (CELG) or into Abbott (ABT) and into Amgen (AMGN) and Biogen (BIIB).	Love	March 12, 2009
mikepush	I think this biotech stock has some big upside ahead of it with great drugs in its pipeline.	Love	March 03, 2009
Buzz	Great drugs such as Revlamid...potential takeover target...wonderful numbers.	Love	February 21, 2009
barrons3	In the larger space I like Celgene [CELG], Genzyme [GENZ] and Teva [TEVA] for their pipelines. Personally, my favorite stock in the space is Celgene, adds Guy Adami.	Love	February 18, 2009
Stockman0212	pharma	Love	February 15, 2009
sarah z	From a recent Mad Money show:"They reported a monster quarter and a big drug approval on Friday. I say that's a good one. Buy it and put it away."	Love	February 04, 2009
bayleer	excellent drug pipeline	Love	January 24, 2009
kevlar	Cure for cancer? They have 3.	Love	January 22, 2009
barrons3	When Microsoft's (MSFT) having trouble with the numbers, do I really want to leave Gilead (GILD) or Celgene (CELG)?	Love	January 22, 2009
arronacosta	Huge growth opportunities, well positioned, fundamentally sound.	Love	January 20, 2009
DocBuzzy	has gone down since I bought it	Hate	January 20, 2009
bboback	goes nowhere	Hate	January 19, 2009
RhinoStocks	According to Cramer, “All the technicians say Celgene has to go lower.” Fitzpatrick wasn’t so sure, explaining that it all depends on your timeframe. With established support (the price a stock has trouble falling below) around $48, he expects a short-term rally when it bounces off a bottom. Long-term, though, Celgene’s chart is “nasty looking,” Fitzpatrick concedes. For the near term, look to play the small rally.	Love	January 19, 2009
barrons3	I remain skeptical of the skeptics in biotech and like Celgene (CELG) ahead of next week's presentation.	Love	January 15, 2009
barrons3	In addition, Huckman also thinks there could be news out of Genzyme [GENZ], Celgene [CELG] and Amgen [AMGN] three other presenters. They could re-affirm their guidance, or provide color on Q4 revenue which would, in turn, move their stocks, he says.	Love	January 14, 2009